Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Takeda/Ovid Plan Phase III For Soticlestat In Dravet Syndrome, But Pull Back On LGS
Aug 25 2020
•
By
Jessica Merrill
Ovid/Takeda reported mixed Phase II data in rare epilepsies • Source: Shutterstock
More from Neurological
More from Therapeutic Category